Angiography/ Cardiac Cath News from StratCenter.com News Archive
StratWire - Complete Business of Cath Lab Newsfeed
http://www.myhealthcarenews.com/RSS/HCC0125.xml
Page: 2 of 3 
- ev3 Announces Global Launch of New PROTEGE EverFlex Self-Expanding Stent System
- AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases
- Angiotech Shares Up on Taxus Registry Data
- PeriCor Therapeutics Reports Positive 2-Year Mortality Results of Acadesine at the American College of Cardiology's Scientific Session
- Adult Stem Cells Improve Cardiac Function and Blood Flow in Patients With Heart Disease, New Study Finds
- Guidant Completes Enrollment in Randomized US Portion of Drug Eluting Stent Pivotal Trial
- Dangers of Stopping Clopidogrel (Plavix ) for Patients with Stents and Certain Other Conditions
- Guidant Plans to Expand CA. Facility
- Guidant expanding Southern CA facilities
- Guidant to Expand Southern CA Facilities
- Guidant Announces Enrollment of 1st Patient in Landmark Carotid Artery Stenting Study
- Medtronic wins patent arbitration case
- Doctor: Artery Disease Caused Heart Attack
- Guidant Accused of Patent Infringement
- SmallCap Sentinel: Reinventing the Biotech Wheel with Nanotechnology
- Medtronic sues Guidant in Ireland over stent
- Boston Scientific to appeal latest J&J verdict
- Medtronic says judge denies motions in stent case
- Judge Rules on Medtronic, Cordis Motions
- Medtronic Sues Guidant in Ireland
- Medtronic, Cordis Motions Denied
- Guidant reports quality problems with some stents
- Earnings Preview: Boston Scientific
- Heart Device Makers Face New Challenge
- Kyphon responds to Medtronic lawsuit
- Boston Scientific Announces Results for Q1 Ended 3/31/2006
- Kyphon Responds to Lawsuit
- Cordis Corp to Develop Global Cardiac and Vascular Institute
- Sorin Group Launches the New Cobalt Chrome Carbostent: CHRONO
- Conor Medsystems Completes Enrollment of COSTAR II Pivotal Randomized Drug-Eluting Stent Trial
- Abbott Closes Guidant Vascular Purchase
- 2 mln Patients Treated With the CYPHER Sirolimus-Eluting Coronary Stent
- Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands
- IDev Technologies Announces the Hiring of a New Executive Mgmt Team
- IDev Technologies Gains CE Mark Approval for New Nitinol Stent in Peripheral Vascular Disease
- Boston Scientific Sues Conor Medsystems Ireland
- Palmaz welcomed into Nat'l Inventor's Hall of Fame
- Med Enclosure - Mgmt Discussion and Analysis of FDA Compliance
- Angiotech Pharmaceuticals announces results for Q1 of 2006
- Moderate-release TAXUS Express coronary stent system demonstrates sustained long-term outcomes in high-risk patients
- TAXUS Liberte Stent System Receives European Approval for 3 Complex Coronary Procedures
- ABIOMED Announces Schedule of Events for Breakthrough IMPELLA Technology at EuroPCR Conference in Paris
- TAXUS ATLAS trial supports superior deliverability and proven outcomes of TAXUS Liberte stent system
- TAXUS Liberte stent system receives European approval for 3 complex coronary procedures
- Study Suggests Drug-Eluting Stent Type and Vessel Size are Important Predictors of Reblockage in Coronary Artery
- Bioenergy: Renowned Cardiothoracic Surgeon Calls Ribose Results Astounding
- Analysis of Heart Attack Patients Suggests Safety Benefit of Thrombus Removal before Placement of Drug Eluting Stents
- FDA Accepts Submission for NitroMist as Complete Response
- Medtronic Announces Key Milestones in Endovascular Repair at Society for Vascular Surgery Meeting
- Larry King Cardiac Foundation Saves 30th Patient of 2006
- Dr Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
- FDA approves Abbott Vascular stent study
- FDA Clears Abbott Stent Trial
- FDA Approves 1st US Study of Stent Placement to Treat Arterial Blockages Below the Knee
- FDA Clears Boston Scientific System for Removing Clots from Arteries
- Ahead of the Bell: Boston Scientific Up
- Court upholds Boston Sci patent win over Medtronic
- Boston Scientific Stents Ruling Upheld
- Biosensors Reports 37% Increase in FYE Product Revenue; Attributable to Sales of Its Drug-Eluting Stents
- Court of Appeals Rules Boston Scientific's Products do Not Infringe Medtronic Stent Patents
- NY State Health Dept Selects Specialty Disease Mgmt Services to Provide New Medicaid Care Mgmt Program in Buffalo and Surrounding Counties
- Cardica's Automated Anastomosis Systems Featured at Cardiac Surgery Conference
- China Pharma Holdings Announced Recent Product Approvals
- Cordis Corp and ClearStream Technologies Group Sign Distribution Agreement for New Balloon Dilation Catheter
- 1st Patient Enrolled in New Prospective, Multi-Center Outcomes Study on SilverHawk Plaque Excision
- Angiotech appoints Jeffrey P Walker as SVP, R&D
- Symphony Medical Announces Initiation of Phase II Multi-Center Clinical Trial for Biologic Therapy to Prevent Post-Operative Atrial Fibrillation
- Cytori Therapeutics Reports Safety and Efficacy of Its Celution System in a Preclinical Study of Coronary Artery Disease
- Micell Technologies and Pacific Northwest Nat'l Lab Receive Prestigious R&D 100 Award for e-RESS Technology
- Boston Scientific's iLab Ultrasound Imaging System Makes it Easier to View Within the Heart and Vessels
- 2nd Federal Vioxx Trial Postponed
- J&J's Cordis Acquires Ensure Medical
- Cordis Corp Acquires Ensure Medical
- FDA OKs updated Kensey Nash system
- Kensey Nash Receives FDA 510 Clearance for TriActiv FX Embolic Protection System
- Procedure to Close Hole in the Heart Featured in Upcoming Akron Children's Hospital Webcast
- OLYMPIA Phase I Registry Demonstrates Efficacy of TAXUS Liberte Stent System in Complex Patients and Lesions
- Biosensors Reports Increase in Product Revenue and Product Gross Margins
- Micell Technologies and Pacific Northwest Nat'l Lab Expand Research Collaboration Involving Supercritical Fluid Technology
- Athersys Receives Approval To Begin Phase I Trial of Lead Obesity Drug
- Abbott Enrolls 1st Patient in New Clinical Trial of XIENCE V Drug Eluting Stent
- Enhanced OptiFlex Supply Chain Mgmt System Delivers Single Integrated Solution for Hospital Cath Labs, Other Special Procedure Units
- CardioTech Appoints Dr Szycher as Special Science Advisor
- Abbott Labs Shares Hit New High
- Isotechnika announces promising results from Phase I TAFA93 trials
- GE Healthcare and Volcano Corp Announce FDA Clearance of Fully-Integrated Intravascular Ultrasound Imaging on the Innova Platform
- New Clinical Data for Cypher Sirolimus-Eluting Coronary Stent & Innovative Cordis Technologies Showcased at World Congress of Cardiology 2006
- Abbott Announces Completion of Enrollment in Groundbreaking Vulnerable Plaque Study
- Conor Medsystems Announces 2-Year Follow-Up Data from EuroSTAR Pivotal Study
- 2-Year Data Suggest Different Rates of Blood Clots and Heart Attacks Between the CYPHER Sirolimus-Eluting Coronary Stent and the Taxus Stent
- Johnson & Johnson Fires Back
- Novadaq Announces European Distribution Contract with Kodak
- Investigators Report New Renal, Mortality and Safety Data From NAPA Trial of NATRECOR
- Abbott Announces Continued Expansion of Vascular Operations in Ireland to Prepare for Drug Eluting Stent Manufacturing
- Safety and Efficacy of Drug-Eluting Stents Reaffirmed in New England Journal of Medicine Articles and Editorial
- Study in New England Journal of Medicine Suggests Heart Attack Patients Fare Better with CYPHER Sirolimus-eluting Coronary Stents Than Bare Metal Stents
- Dynatek dalta Scientific Instruments: Dynatek Announces Off-Axis Stent and Stent-Graft Testing
- PLC Medical Systems and Miltenyi Biotec Sponsor Presentation on Stem Cell Therapy in Cardiac Surgery
- Stem Cell Trials Show Sustained Heart Function Improvement
- Medtronic devices get approvals